Full Text View
Tabular View
No Study Results Posted
Related Studies
Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis
This study is ongoing, but not recruiting participants.
Study NCT00586651   Information provided by Cephalon
First Received: December 21, 2007   Last Updated: July 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Polycythemia Vera
Essential Thrombocytosis
Additional conditions recognized in this trial
Polycythemia
Thrombocythemia, Hemorrhagic
Thrombocytosis
More general conditions related to this trial
Blood Coagulation Disorders
Blood Platelet Disorders
Bone Marrow Diseases
Hematologic Diseases
Hemorrhagic Disorders
Myeloproliferative Disorders
Interventions listed in this trial
lestaurtinib
Sponsors listed in this trial
Cephalon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services